Daktari Diagnostics
Cambridge, US · Delaware corporation · 2 known investors
Find your way into Daktari Diagnostics
451 people in our graph share verified history with the Daktari Diagnostics team — schools, employers, funds. One of them is your warm intro.
John Kimunlockedknows Bill Rodriguez · together at Brown University (overlapped)
.png)
×4knows the team · via Massachusetts General Hospital
knows the team · via Harvard Medical School
×3knows the team · via Brigham and Women's Hospital
knows the team · via Yale School of Medicine
×2knows the team · via Clinton Foundation
Founders & leadership
WR
DH
Donald HawthorneExecutive
Board
AS
RK
Roger KittermanBoard director
ER
Edward RobertsBoard director
PK
Peter KasparBoard director
TB
Thierry BernardBoard director
DR
David RubinBoard director
CE
Christopher EarlBoard director
SL
Stanley LapidusBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$42.5M disclosed across 2 rounds · 2013–2015
▶$22.5MraisedMay 2016 · 31 investors · BiotechnologyRule 506(b)
▶$22.5MraisedMay 2016 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter KasparDirector
- Aaron SandoskiDirector
- Thierry BernardDirector
- David RubinDirector
- Donald HawthorneExecutive Officer, Director
- Offering amount
- $22.5M
- Amount sold
- $22.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedApr 2014 · 27 investors · BiotechnologyRule 506(b)
▶$20MraisedApr 2014 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron SandoskiDirector
- Christopher EarlDirector
- Stanley LapidusDirector
- Roger KittermanDirector
- William RodriguezExecutive Officer, Director
- David RubinDirector
- Edward RobertsDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $221.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $649.6K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase I | 2016 | $148K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $448.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $153.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Daktari Diagnostics?
- Daktari Diagnostics was founded by William Rodriguez.
- Who are Daktari Diagnostics's investors?
- Daktari Diagnostics's investors include Boston Harbor Angels, Norwich Ventures.
- How much funding has Daktari Diagnostics raised?
- Daktari Diagnostics has disclosed $42.5M raised across 2 rounds.
- Where is Daktari Diagnostics headquartered?
- Daktari Diagnostics is headquartered in Cambridge, US.